TY - JOUR AU - Chitapanarux, Imjai AU - Charoentum, Chaiyut AU - Traisathit, Patrinee PY - 2018 TI - Nedaplatin: a new paradigm in nasopharyngeal cancer JF - Annals of Nasopharynx Cancer; Vol 2 (June 2018): Annals of Nasopharynx Cancer Y2 - 2018 KW - N2 - Radiotherapy concurrent with cisplatin either weekly or every 3 weeks’ regimen has been accepted as the standard of care for locoregional advanced stage of nasopharyngeal cancer for decades (1-5). Although it has shown a statistically significant benefit in terms of locoregional control and survival rate when compared with radiotherapy alone, but severe acute and late toxicities might affect the quality of life (QoL), mainly nausea, vomiting, impaired renal function, and hearing toxicity (6-9). UR - https://anpc.amegroups.org/article/view/4368